Lagis Enterprise Valuation
Is 6730 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 6730 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 6730 (NT$38.15) is trading above our estimate of fair value (NT$21.48)
Significantly Below Fair Value: 6730 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 6730?
Key metric: As 6730 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is 6730's PE Ratio? | |
|---|---|
| PE Ratio | 16.8x |
| Earnings | NT$72.80m |
| Market Cap | NT$1.21b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.9x |
| Enterprise Value/EBITDA | 12.6x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does 6730's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 38.3x | ||
4744 CVC Technologies | 100x | n/a | NT$1.1b |
3184 MicroBase Technology | 16x | n/a | NT$1.0b |
4161 Bioptik Technology Incorporation | 17.4x | n/a | NT$1.7b |
6527 Crystalvue Medical | 19.8x | n/a | NT$2.3b |
6730 Lagis Enterprise | 16.8x | n/a | NT$1.2b |
Price-To-Earnings vs Peers: 6730 is good value based on its Price-To-Earnings Ratio (16.8x) compared to the peer average (38.3x).
Price to Earnings Ratio vs Industry
How does 6730's PE Ratio compare vs other companies in the TW Medical Equipment Industry?
| 0 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: 6730 is good value based on its Price-To-Earnings Ratio (16.8x) compared to the TW Medical Equipment industry average (19.6x).
Price to Earnings Ratio vs Fair Ratio
What is 6730's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 16.8x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 6730's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Concord Medical
NT$866.7m
Provides hospital management support services in Taiwan, Myanmar, and China.
6518
NT$25.85
7D
-3.7%
1Y
9.5%
Universal Vision Biotechnology
NT$18.0b
Operates a chain of eye care clinics in Taiwan and China.
3218
NT$214.50
7D
1.4%
1Y
-27.4%
Pacific Hospital Supply
NT$6.4b
Manufactures, processes, and sells medical disposable products and equipment in Taiwan.
4126
NT$88.60
7D
-0.3%
1Y
5.2%